• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤位置对pT3N0M0上尿路尿路上皮癌的预后影响:一项回顾性队列研究

The Prognostic Impact of Tumor Location in pT3N0M0 Upper Urinary Tract Urothelial Carcinoma: A Retrospective Cohort Study.

作者信息

Chen Tzu Shuang, Chen Yen Ta, Wang Hung Jen, Chiang Po Hui, Yang Wen Chou, Lee Wei Ching, Chuang Yao Chi, Cheng Yuan Tso, Kang Chih Hsiung, Lee Wei Chia, Chen Chien Hsu, Shen Yuan Chi, Liu Yi Yang, Liu Hui Ying, Chang Yin Lun, Su Yu Li, Huang Chun Chieh, Luo Hao Lun

机构信息

Department of Urology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.

Jhong Siao Urological Hospital, Kaohsiung, Taiwan.

出版信息

Front Oncol. 2022 Mar 15;12:850874. doi: 10.3389/fonc.2022.850874. eCollection 2022.

DOI:10.3389/fonc.2022.850874
PMID:35372015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8964942/
Abstract

BACKGROUND

We aimed to evaluate the impact of tumor location on cancer outcomes in patients with pT3N0M0 upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy (RNU) with bladder cuff excision.

MATERIALS AND METHODS

We retrospectively reviewed 302 patients with pT3N0M0 UTUC who underwent RNU with bladder cuff excision at our institution between 2005 and 2019, including 191 renal pelvis tumors and 111 ureteral tumors. Clinicopathologic characteristics were compared between renal pelvis and ureter urothelial carcinomas. Multivariate Cox proportional hazard regression was used to assess the association between outcomes and clinical factors. Outcomes of interest included intravesical recurrence-free survival (IVRFS), local recurrence-free survival (LRFS), distant metastasis-free survival (DMFS), and cancer-specific survival (CSS), which were measured using the Kaplan-Meier curve with a log-rank test.

RESULTS

A total of 302 patients underwent RNU with bladder cuff excision. During the median follow-up of 42.7 months, 70 (23.2%), 95 (31.5%), and 99 (32.8%) patients experienced intravesical recurrence, local recurrence, and distant metastasis, respectively. Seventy (23.2%) patients died from UTUC. Multivariate Cox regression analysis showed that tumor location was an independent predictor of local recurrence (HR = 2.05, p = 0.001), with borderline independent significance in intravesical recurrence (HR = 1.54, p = 0.074) and distant metastasis (HR = 1.45, p = 0.08). Kaplan-Meier analysis showed that ureter tumors had a worse 5-year local recurrence (log-rank p < 0.001) and borderline worse 5-year intravesical recurrence (log-rank p = 0.055) and 5-year distant metastasis (log-rank p = 0.073).

CONCLUSION

Ureter tumors seem to be associated with worse oncological outcomes, especially with local recurrence in UTUC. Further large and long-term studies are warranted for investigating biological differences based on tumor location.

摘要

背景

我们旨在评估肿瘤位置对接受根治性肾输尿管切除术(RNU)并切除膀胱袖口的pT3N0M0上尿路尿路上皮癌(UTUC)患者癌症预后的影响。

材料与方法

我们回顾性分析了2005年至2019年间在我院接受RNU并切除膀胱袖口的302例pT3N0M0 UTUC患者,其中包括191例肾盂肿瘤和111例输尿管肿瘤。比较肾盂和输尿管尿路上皮癌的临床病理特征。采用多变量Cox比例风险回归分析评估预后与临床因素之间的关联。感兴趣的预后指标包括膀胱内无复发生存期(IVRFS)、局部无复发生存期(LRFS)、远处无转移生存期(DMFS)和癌症特异性生存期(CSS),使用Kaplan-Meier曲线和对数秩检验进行测量。

结果

共有302例患者接受了RNU并切除膀胱袖口。在中位随访42.7个月期间,分别有70例(23.2%)、95例(31.5%)和99例(32.8%)患者出现膀胱内复发、局部复发和远处转移。70例(23.)患者死于UTUC。多变量Cox回归分析显示,肿瘤位置是局部复发的独立预测因素(HR = 2.05,p = 0.001),在膀胱内复发(HR = 1.54,p = 0.074)和远处转移(HR = 1.45,p = 0.08)方面具有临界独立意义。Kaplan-Meier分析显示,输尿管肿瘤的5年局部复发情况较差(对数秩p < 0.001),5年膀胱内复发情况临界较差(对数秩p = 0.055),5年远处转移情况临界较差(对数秩p = 0.073)。

结论

输尿管肿瘤似乎与更差的肿瘤学预后相关,尤其是UTUC中的局部复发。有必要进行进一步的大型长期研究,以探讨基于肿瘤位置的生物学差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9816/8964942/f065b9c246c0/fonc-12-850874-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9816/8964942/2229de123722/fonc-12-850874-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9816/8964942/9439049c2713/fonc-12-850874-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9816/8964942/6dd9332f400e/fonc-12-850874-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9816/8964942/f065b9c246c0/fonc-12-850874-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9816/8964942/2229de123722/fonc-12-850874-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9816/8964942/9439049c2713/fonc-12-850874-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9816/8964942/6dd9332f400e/fonc-12-850874-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9816/8964942/f065b9c246c0/fonc-12-850874-g004.jpg

相似文献

1
The Prognostic Impact of Tumor Location in pT3N0M0 Upper Urinary Tract Urothelial Carcinoma: A Retrospective Cohort Study.肿瘤位置对pT3N0M0上尿路尿路上皮癌的预后影响:一项回顾性队列研究
Front Oncol. 2022 Mar 15;12:850874. doi: 10.3389/fonc.2022.850874. eCollection 2022.
2
Tumor Location Based Segmentation in Upper-Tract Urothelial Carcinoma Impacts on the Urothelial Recurrence-Free Survival: A Multi-Institutional Database Study.基于肿瘤位置的上尿路尿路上皮癌分割对无尿路上皮复发生存的影响:一项多机构数据库研究
Curr Urol. 2020 Dec;14(4):183-190. doi: 10.1159/000499240. Epub 2020 Dec 18.
3
Ten-year survival outcomes after radical nephroureterectomy with a risk-stratified approach using prior diagnostic ureteroscopy: a single-institution observational retrospective cohort study.基于术前诊断性输尿管镜检查的风险分层方法行根治性肾输尿管切除术的 10 年生存结果:单机构观察性回顾性队列研究。
BJU Int. 2022 Jun;129(6):744-751. doi: 10.1111/bju.15627. Epub 2021 Nov 24.
4
The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence.在上尿路尿路上皮癌行根治性肾输尿管切除术之前行诊断性输尿管镜检查与膀胱内复发率升高无关。
World J Surg Oncol. 2018 Jul 9;16(1):135. doi: 10.1186/s12957-018-1411-9.
5
Oncological impact of different distal ureter managements during radical nephroureterectomy for primary upper urinary tract urothelial carcinoma.原发性上尿路尿路上皮癌根治性肾输尿管切除术期间不同远端输尿管处理方式的肿瘤学影响
World J Clin Cases. 2020 Nov 6;8(21):5104-5115. doi: 10.12998/wjcc.v8.i21.5104.
6
Factors Predicting Oncological Outcomes of Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma in Taiwan.台湾上尿路尿路上皮癌根治性肾输尿管切除术肿瘤学结局的预测因素
Front Oncol. 2022 Jan 13;11:766576. doi: 10.3389/fonc.2021.766576. eCollection 2021.
7
Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.非肌层浸润性膀胱肿瘤史对上尿路尿路上皮癌患者的预后意义。
Urol Oncol. 2013 Nov;31(8):1615-20. doi: 10.1016/j.urolonc.2012.03.004. Epub 2012 Apr 21.
8
Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.根治性肾输尿管切除术治疗后局限性上尿路上皮癌患者膀胱内复发的危险因素和肿瘤学结果:一项倾向评分匹配的病例对照研究。
Int J Surg. 2020 Apr;76:28-34. doi: 10.1016/j.ijsu.2020.02.015. Epub 2020 Feb 17.
9
Effects of Complete Bladder Cuff Removal on Oncological Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.完全去除膀胱袖套对根治性肾输尿管切除术治疗上尿路尿路上皮癌的肿瘤学结局的影响。
Cancer Res Treat. 2021 Jul;53(3):795-802. doi: 10.4143/crt.2020.919. Epub 2020 Dec 28.
10
Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.在上尿路尿路上皮癌患者接受肾输尿管切除术和膀胱袖状切除术治疗中,肿瘤位置与多灶性的影响:无围手术期化疗的同质系列。
BJU Int. 2012 Jul;110(2 Pt 2):E7-13. doi: 10.1111/j.1464-410X.2011.10792.x. Epub 2011 Dec 16.

引用本文的文献

1
Influence of tumour location on the survival outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy.肿瘤位置对接受根治性肾输尿管切除术治疗的上尿路尿路上皮癌生存结局的影响。
World J Urol. 2025 May 3;43(1):261. doi: 10.1007/s00345-024-05432-0.
2
Improving Risk Stratification in pT3 Upper Tract Urothelial Carcinoma: A Focus on Invasion Patterns.改善pT3上尿路尿路上皮癌的风险分层:关注浸润模式。
Cancers (Basel). 2025 Mar 8;17(6):923. doi: 10.3390/cancers17060923.
3
Performance of ChatGPT in providing patient information about upper tract urothelial carcinoma.

本文引用的文献

1
Robot-assisted segmental ureterectomy with psoas hitch ureteral reimplantation: Oncological, functional and perioperative outcomes of case series of a single centre.机器人辅助节段性输尿管切除术联合腰大肌悬带输尿管再植术:单中心病例系列的肿瘤学、功能和围手术期结果。
Arch Ital Urol Androl. 2021 Mar 22;93(1):101-106. doi: 10.4081/aiua.2021.1.101.
2
The Prognostic Impact of Tumor Architecture for Upper Urinary Tract Urothelial Carcinoma: A Propensity Score-Weighted Analysis.肿瘤结构对上尿路尿路上皮癌的预后影响:一项倾向评分加权分析
Front Oncol. 2021 Feb 25;11:613696. doi: 10.3389/fonc.2021.613696. eCollection 2021.
3
Prognostic Significance of Primary Tumor Location in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Retrospective, Multi-Center Cohort Study in Taiwan.
ChatGPT在提供上尿路尿路上皮癌患者信息方面的表现。
Contemp Oncol (Pozn). 2024;28(2):172-181. doi: 10.5114/wo.2024.141567. Epub 2024 Aug 23.
4
Upper Tract Urothelial Carcinoma (UTUC): Prevalence, Impact and Management Challenge.上尿路尿路上皮癌(UTUC):患病率、影响及管理挑战
Cancer Manag Res. 2024 May 17;16:467-475. doi: 10.2147/CMAR.S445529. eCollection 2024.
5
Upper Tract Urothelial Carcinoma: A Narrative Review of Current Surveillance Strategies for Non-Metastatic Disease.上尿路尿路上皮癌:非转移性疾病当前监测策略的叙述性综述
Cancers (Basel). 2023 Dec 20;16(1):44. doi: 10.3390/cancers16010044.
肾输尿管切除术治疗上尿路尿路上皮癌时原发肿瘤位置的预后意义:台湾一项回顾性多中心队列研究
J Clin Med. 2020 Nov 27;9(12):3866. doi: 10.3390/jcm9123866.
4
Ureteral location is associated with survival outcomes in upper tract urothelial carcinoma: A population-based analysis.输尿管位置与上尿路尿路上皮癌的生存结局相关:一项基于人群的分析。
Int J Urol. 2020 Nov;27(11):966-972. doi: 10.1111/iju.14336. Epub 2020 Aug 9.
5
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.欧洲泌尿外科学会上尿路尿路上皮癌指南:2020 年更新版。
Eur Urol. 2021 Jan;79(1):62-79. doi: 10.1016/j.eururo.2020.05.042. Epub 2020 Jun 24.
6
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial.在上尿路尿路上皮癌中的辅助化疗(POUT 试验):一项 3 期、开放标签、随机对照试验。
Lancet. 2020 Apr 18;395(10232):1268-1277. doi: 10.1016/S0140-6736(20)30415-3. Epub 2020 Mar 5.
7
Unusual presentation of upper urinary tract urothelial carcinoma in Taiwan: Direct comparison from Taiwan-Japan UTUC Collaboration Cohort.台湾上尿路尿路上皮癌的不常见表现:来自台湾-日本 UTUC 协作队列的直接比较。
Int J Urol. 2020 Apr;27(4):327-332. doi: 10.1111/iju.14188. Epub 2020 Feb 25.
8
Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.根治性肾输尿管切除术治疗后局限性上尿路上皮癌患者膀胱内复发的危险因素和肿瘤学结果:一项倾向评分匹配的病例对照研究。
Int J Surg. 2020 Apr;76:28-34. doi: 10.1016/j.ijsu.2020.02.015. Epub 2020 Feb 17.
9
Adjuvant Treatments for Advanced Stage, Non-metastatic Upper Tract Urothelial Carcinoma: A Multicenter Study.晚期非转移性上尿路尿路上皮癌的辅助治疗:一项多中心研究。
Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):819-827. doi: 10.1016/j.ijrobp.2019.03.027. Epub 2019 Mar 26.
10
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.